147 related articles for article (PubMed ID: 38294309)
1. Reduced mortality, complications, and economic burden among medicare beneficiaries receiving influenza antivirals.
Best JH; Reddy SR; Chang E; Bognar K; Tarbox MH; Cagas SE; Seetasith A
J Med Econ; 2024; 27(1):240-252. PubMed ID: 38294309
[TBL] [Abstract][Full Text] [Related]
2. Burden of influenza in patients with cardiovascular disease who receive antiviral treatment for influenza.
Corral M; Castro RC; To TM; Arndorfer S; Wang S; Stephens J
J Med Econ; 2022; 25(1):1061-1067. PubMed ID: 35943115
[TBL] [Abstract][Full Text] [Related]
3. Economic burden and secondary complications of influenza-related hospitalization among adults in the US: a retrospective cohort study.
Hu T; Miles AC; Pond T; Boikos C; Maleki F; Alfred T; Lopez SMC; McGrath L
J Med Econ; 2024; 27(1):324-336. PubMed ID: 38343288
[TBL] [Abstract][Full Text] [Related]
4. The Increased Clinical and Economic Burden of Hyperkalemia in Medicare Patients Admitted to Long-Term Care Settings.
Neuenschwander JF; Silverstein AR; Teigland CL; Kumar S; Zeng EY; Agiro AT; Pottorf WJ; Peacock WF
Adv Ther; 2023 Mar; 40(3):1204-1223. PubMed ID: 36652174
[TBL] [Abstract][Full Text] [Related]
5. Antiviral use is associated with a decrease in the rate of influenza-related complications, health care resource utilization, and costs.
Wallick C; Wu N; To TM; Keebler D; Moawad D
J Med Econ; 2021; 24(1):386-393. PubMed ID: 33571032
[TBL] [Abstract][Full Text] [Related]
6. Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population.
Blanchette CM; Gutierrez B; Ory C; Chang E; Akazawa M
J Manag Care Pharm; 2008 Mar; 14(2):176-85. PubMed ID: 18331119
[TBL] [Abstract][Full Text] [Related]
7. Real-World Economic Outcomes During Time on Treatment Among Patients Who Initiated Sunitinib or Pazopanib as First Targeted Therapy for Advanced Renal Cell Carcinoma: A Retrospective Analysis of Medicare Claims Data.
Vogelzang NJ; Pal SK; Ghate SR; Li N; Swallow E; Peeples M; Zichlin ML; Meiselbach MK; Perez JR; Agarwal N
J Manag Care Spec Pharm; 2018 Jun; 24(6):525-533. PubMed ID: 29799328
[TBL] [Abstract][Full Text] [Related]
8. Incidence, economic burden, and treatment of acute respiratory tract infection in hematopoietic stem cell transplantation recipients using real world data in Japan: a retrospective claims data analysis.
Wattanakamolkul K; Nakayama Y
J Med Econ; 2022; 25(1):870-879. PubMed ID: 35703058
[TBL] [Abstract][Full Text] [Related]
9. Healthcare utilization and cost burden of Huntington's disease among Medicare beneficiaries in the United States.
Exuzides A; Reddy SR; Chang E; Ta JT; Patel AM; Paydar C; Yohrling GJ
J Med Econ; 2021; 24(1):1327-1336. PubMed ID: 34730477
[TBL] [Abstract][Full Text] [Related]
10. Cost savings for pVAD compared to ECMO in the management of acute myocardial infarction complicated by cardiogenic shock: An episode-of-care analysis.
Vetrovec GW; Lim MJ; Needham KA
Catheter Cardiovasc Interv; 2021 Oct; 98(4):703-710. PubMed ID: 32790231
[TBL] [Abstract][Full Text] [Related]
11. Impact of oseltamivir on the incidence of secondary complications of influenza in adolescent and adult patients: results from a retrospective population-based study.
Blumentals WA; Schulman KL
Curr Med Res Opin; 2007 Dec; 23(12):2961-70. PubMed ID: 17939881
[TBL] [Abstract][Full Text] [Related]
12. Falls, healthcare resources and costs in older adults with insomnia treated with zolpidem, trazodone, or benzodiazepines.
Amari DT; Juday T; Frech FH; Wang W; Wu Z; Atkins N; Wickwire EM
BMC Geriatr; 2022 Jun; 22(1):484. PubMed ID: 35658904
[TBL] [Abstract][Full Text] [Related]
13. Does influenza vaccination of older adult Medicare beneficiaries lower treatment costs for acute and chronic respiratory disease?
Stuart B; Davidoff A; Lloyd J; Shaffer T; Shoemaker JS; Kemner J
Am J Geriatr Pharmacother; 2010 Jun; 8(3):201-14. PubMed ID: 20624610
[TBL] [Abstract][Full Text] [Related]
14. Incremental health care resource utilization and costs associated among patients with Parkinson's disease psychosis and incident dementia: An analysis of medicare beneficiaries.
Rajagopalan K; Rashid N; Gopal D; Doshi D
Int J Geriatr Psychiatry; 2023 Nov; 38(11):e6017. PubMed ID: 37936540
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of antiviral treatment for influenza in type 2 diabetes.
Lewing BD; Wallick C; To TM; Masters H; Dayal P; Korom SW; Tam S
Am J Manag Care; 2023 Feb; 29(2):e43-e50. PubMed ID: 36811987
[TBL] [Abstract][Full Text] [Related]
16. Health Care Resource Utilization and Costs for Patients with Spinal Muscular Atrophy: Findings from a Retrospective US Claims Database Analysis.
Toro W; Yang M; Georgieva M; Song W; Patel A; Jiang AX; Zhao A; LaMarca N; Dabbous O
Adv Ther; 2023 Oct; 40(10):4589-4605. PubMed ID: 37587305
[TBL] [Abstract][Full Text] [Related]
17. Antiviral Use and Health Care Use Among US Patients With Rheumatoid Arthritis and Influenza in Three Influenza Seasons, 2016-2019.
Neuberger EE; To TM; Seetasith A; Arndorfer SM; Wallick CJ
ACR Open Rheumatol; 2022 Jul; 4(7):631-639. PubMed ID: 35559601
[TBL] [Abstract][Full Text] [Related]
18. Healthcare resource utilization and costs in patients with myelodysplastic syndromes treated with hypomethylating agents: a SEER-Medicare analysis.
Stein EM; Bonifacio G; Latrémouille-Viau D; Shi S; Guérin A; Wu EQ; Sadek I; Cao X
J Med Econ; 2021; 24(1):234-243. PubMed ID: 33472483
[TBL] [Abstract][Full Text] [Related]
19. The Hospital Burden of Flu in Italy: a retrospective study on administrative data from season 2014-2015 to 2018-2019.
Cipelli R; Falato S; Lusito E; Maifredi G; Montedoro M; Valpondi P; Zucchi A; Azzi MV; Zanetta L; Gualano MR; Xoxi E; Marchisio PG; Castaldi S
BMC Infect Dis; 2024 Jun; 24(1):572. PubMed ID: 38851739
[TBL] [Abstract][Full Text] [Related]
20. Treatment Patterns and Associated Health Care Costs Before and After Treatment Initiation Among Pulmonary Arterial Hypertension Patients in the United States.
Burger CD; Ozbay AB; Lazarus HM; Riehle E; Montejano LB; Lenhart G; White RJ
J Manag Care Spec Pharm; 2018 Aug; 24(8):834-842. PubMed ID: 29436260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
